Article
Value of Genetically Rare Cord Blood Units Beyond Conventional Quality Metrics.
HLA - 1 Jul 2026
Selma-Soriano Estela, Valero-Hervás Diana, Boix Francisco, Planelles Dolores, Vera Belén, Vayá María Jesús, Arbona Cristina, Larrea Luis
Abstract excerpt
Allogeneic haematopoietic stem cell transplantation (HSCT) is a cornerstone therapy for haematological and genetic disorders. Owing to the limited availability of HLA-identical related donors, umbilical cord blood (UCB) has become a valuable alternative source of haematopoietic progenitors. However, many UCB units are excluded from banking based on quality criteria, despite potentially harbouring rare and...
Topics
Join the communities discussing this publication.
